Please login to the form below
CoStim Pharmaceuticals
This page shows the latest CoStim Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.
Novartis enters PD-1 race via CoStim acquisition
Expands presence in cancer immunotherapies. Novartis has reached a deal to acquire US company CoStim Pharmaceuticals, expanding its position in the hot topic of cancer immunotherapy. ... Boston, Massachusetts-based CoStim - which started operations in
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Featured jobs
- Experienced / Senior Medical Writer - Excellent Progression Oppo...
-
Excellent Salary and Benefits on offer
-
Senior Medical Writer
-
Salary TBC
- Editorial Assistants - Medical Communications agency - Cheshire
-
Excellent Remuneration Package
- Senior Medical Writer – Medical Communications – North West – In...
-
Excellent Remuneration Package
-
Account Director, Medical Education
-
Salary TBC
- Senior / Principal Medical Writers wanted - MedComms - Various U...
-
Excellent Remuneration Packages
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Senior Account Manager / Account Director - MedComms - London
-
Highly competitive salary &package
-
Senior Copywriter
-
Salary TBC
Subscribe to our email news alerts
- Leading AstraZeneca’s return to growth in Europe
- Eli Lilly shutters UK neuroscience unit, with 80 job losses expected
- Takeda offloads select portfolio to Acino ahead of Shire takeover
- Roche reports continued growth in Q3, despite biosimilar competition
- Roche eyes filings for Tecentriq/Avastin combo in liver cancer
- Bayer/J&J claim new FDA okay for clot drug Xarelto
- Tapping the potential of rare diseases: A journey into uncharted territory
- COUCH Health, embarks on a 3-year long mission to improve 1 million lives
- The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments
- Come meet Valid Insight at booth C2-006 at ISPOR Europe 2019
- Vertex scores FDA approval for CF triple therapy Trikafta
- Seattle Genetics preps filing next year for oral HER2 drug
PMHub
W2O Group
W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...
Latest intelligence
- Tapping the potential of rare diseases: A journey into uncharted territory
- ...
- The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments
- The essential medicine list (EML) contains treatments considered to be the most effective and safe in targeting global health concerns. On 9 July 2019, the World Health Organization (WHO) published...
- Evolution or revolution: the latest review of NICE methods
- By Leela Barham...
Quick links
Infographics
